Package Leaflet: Information for the User
LAMBDALINA 40 mg/g Cream
Lidocaine
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
LAMBDALINA 40 mg/g cream contains lidocaine and is a medicine that induces local loss of sensitivity (local anesthesia) of the skin.
LAMBDALINA is used to desensitize the skin in relation to needle insertion (e.g. prior to blood tests).
Do not use LAMBDALINA
Warnings and precautions
Consult your doctor or pharmacist before starting to use LAMBDALINA:
Please inform your doctor if you are affected by any of the above-mentioned situations.
LAMBDALINA should only be used on undamaged skin (not on mucous membranes, wounds, or eczema).
Other medicines and LAMBDALINA
Tell your doctor or pharmacist if you are using or have recently used or might use any other medicines.
It is especially important for your doctor to know if you have been treated with any of the following medicines, as the risk of side effects may be increased:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine.
Occasional use of LAMBDALINA during pregnancy is unlikely to cause harmful effects on the fetus.
LAMBDALINA passes into breast milk but is unlikely to affect the baby during breastfeeding.
Driving and using machines
LAMBDALINA has no known influence on the ability to drive and use machines.
LAMBDALINA contains propylene glycol, benzyl alcohol, hydrogenated soybean lecithin, and polysorbate 80.This medicine contains 75 mg of propylene glycol per gram of cream. Propylene glycol may cause skin irritation.
Lambdalina contains hydrogenated soybean lecithin. If you are allergic to peanuts or soy, do not use this medicine.
This medicine contains 15 mg of benzyl alcohol per gram of cream. Benzyl alcohol may cause allergic reactions and may cause moderate local irritation.
This medicine contains polysorbate 80, which may cause allergic reactions.
Follow exactly the administration instructions of LAMBDALINA indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is:
Children from6 to12 years:
The single dose to be applied is 2-3g. The recommended application time, i.e. the time the cream should be on the skin, is 60 minutes, but never more than two hours.
Adolescents over 12 years and adults:
The single dose to be applied is 2-3g. The maximum daily dose is 5 grams. The recommended application time is 60 minutes, but never more than two hours.
Children from2 to6 years:
Since there is not enough experience, LAMBDALINA is not recommended for this age group.
Children from0 to2 years:
Since there is no experience, LAMBDALINA should not be used for this age group.
1 gram of cream corresponds to approximately 2.5 cm in length.
| |
A dressing is recommended to prevent the cream from accidentally coming off before the end of the application time. | |
Close the tube after use. |
If you think that the effect of LAMBDALINA is too strong or too weak, please consult your doctor or pharmacist.
If you use more LAMBDALINA than you should
Overdose is unlikely with normal use on undamaged skin.
If you have used more LAMBDALINA than you should, or if a child has accidentally ingested the medicine or too much has been applied to the skin, please contact your doctor or hospital for a risk assessment and advice.
In case of overdose or accidental ingestion, consult the Toxicology Information Service, phone 91562 04 20.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Uncommon (1 to 10 in 1000 people treated):
Local skin reactions (pallor, redness, itching, and burning) in the treated area. The symptoms are usually transient and mild.
Rare (1 to 10 in 10,000 people treated):
Allergic contact eczema.
Very rare (less than 1 in 10,000 people treated)
Allergic reactions (in severe cases, anaphylactic shock)
Stop using LAMBDALINA and contact your doctor immediately if you have any of the following symptoms (anaphylactic shock)
If you think any of the side effects you are experiencing are serious or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet.
You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and tube after EXP. The expiry date is the last day of the month stated.
Do not store above 30°C.
After opening the tube, the shelf life is 6 months.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of LAMBDALINA
Appearance and packaging
LAMBDALINA is a white to yellowish cream.
Presentation: 5 g, 10 g, 20 g, 30 g, 40 g, and 50 g in aluminum tubes. Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder:
ISDIN, SA
Provençals 33
08019 Barcelona
Spain
Manufacturer:
Medinfar Manufacturing S.A.
Parque Industrial Armando Martins Tavares
Rua Outeiro da Armada, 5
Condeixa-a-Nova
3150-194 Sebal
Portugal
Date of last revision of this leaflet: May 2025
The average price of LAMBDALINA 40 mg/g CREAM in October, 2025 is around 15.64 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.